Otte, J. L., Flockhart, D., Storniolo, A. M., Schneider, B., Azzouz, F., Lemler, S., et al. (2009).
Comparison of subjective and objective hotflash measures over time among breast cancer
survivors initiating aromatase inhibitor therapy.Menopause, 16(4), 653.
Perz, J. M. (1997). Development of the menopause symptom list: A factor analytic study of
menopause associated symptoms. Women and Health, 25(1), 53–69. doi:10.1300/
J013v25n01_04
Quan, N., Xin, L., & Blatteis, C. M. (1991). Microdialysis of norepinephrine into preoptic area of
guinea pigs: Characteristics of hypothermic effect. American Journal of
Physiology-Regulatory, Integrative and Comparative Physiology, 261(2), R378–R385.
Regestein, Q. R. (2006). Hotflashes and sleep.Menopause, 13(4), 549–552. doi:10.1097/01.gme.
0000227395.30321.ff
Reynolds, S. (1941). Dermovascular action of estrogen, the ovarian follicular hormone.Journal of
Investigative Dermatology, 4(1), 7–22. doi:10.1038/jid.1941.3
Rickles, W., & Day, J. (1968). Electrodermal activity in non-palmer skin sites.Psychophysiology,
4 (4), 421–435.
Savard, M. H., Savard, J., & Ivers, H. (2014). Validation of a sternal skin conductance criterion for
measuring hotflashes in breast cancer patients.Menopause, 21(2), 165–169. doi:10.1097/
GME.0b013e3182947af3
Savard, M. H., Savard, J., Quesnel, C., & Ivers, H. (2009). The influence of breast cancer treatment
on the occurrence of hotflashes.Journal of Pain and Symptom Management, 37(4), 687–697.
doi:10.1016/j.jpainsymman.2008.04.010
Shiffman, S., Hufford, M. R., & Paty, J. (2001). Subject experience diaries in clinical research, Part
1: The patient experience movement.Applied Clinical Trials, 10(2), 46–57.
Sievert, L. L. (2007). Variation in sweating patterns: Implications for studies of hotflashes through
skin conductance.Menopause, 14(4), 742–751. doi:10.1097/gme.0b013e3180577841
Sievert, L.L. (2012).Choosing the gold standard: Subjective report vs. physiological measure
(Vol. 5, No. 3, pp. e1–e18). Insights, Institute of Advanced Study, Durham University, UK.
Sievert, L. L. (2014). Menopause across cultures: Clinical considerations.Menopause, 21(4), 421–
- doi:10.1097/GME.0000000000000099
Sievert, L. L., Begum, K., Sharmeen, T., Chowdhury, O., Muttukrishna, S., & Bentley, G. (2008).
Patterns of occurrence and concordance between subjective and objective hotflashes among
Muslim and Hindu women in Sylhet, Bangladesh.American Journal of Human Biology, 20(5),
598 – 604. doi:10.1002/Ajhb.20785
Sievert, L. L., & Espinosa-Hernandez, G. (2003). Attitudes toward menopause in relation to
symptom experience in Puebla, Mexico.Women and Health, 38(2), 93–106. doi:10.1300/
J013v38n02_07
Sievert, L. L., Freedman, R. R., Garcia, J. Z., Foster, J. W., del Carmen Romano Soriano, M.,
Longcope, C., et al. (2002). Measurement of hotflashes by sternal skin conductance and
subjective hotflash report in Puebla, Mexico.Menopause, 9(5), 367–376.
Sievert, L. L., Vidovic, M., Horak, H., & Abel, M. (2004). Age and symptom experience at
menopause in the Selska Valley, Slovenia.Menopause, 11(2), 223–227. doi:10.1097/01.Gme.
0000087982.28957.14
Sloan, J. A., Loprinzi, C. L., Novotny, P. J., Barton, D. L., Lavasseur, B. I., & Windschitl, H.
(2001). Methodologic lessons learned from hotflash studies.Journal of Clinical Oncology, 19
(23), 4280–4290.
Spetz, A. C., Hammar, M., Lindberg, B., Spangberg, A., & Varenhorst, E. (2001). Prospective
evaluation of hotflashes during treatment with parenteral estrogen or complete androgen
ablation for metastatic carcinoma of the prostate.Journal of Urology, 166(2), 517–520.
Stefanopoulou, E., & Hunter, M. S. (2013). Does pattern recognition software using the Bahr
monitor improve the sensitivity, specificity, and concordance of ambulatory skin conductance
monitoring of hot flushes? Menopause, 20(11), 1133–1138. doi:10.1097/GME.
0b013e3182894f6d
252 W.I. Fisher and R.C. Thurston